| Date Filed | Type | Description |
| 09/29/2023 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 294 shares
@ $8.38, valued at
$2.5k
|
|
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 294 shares
@ $12.12, valued at
$3.6k
|
|
| 06/01/2023 |
4/A
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 2,012 shares
@ $11.16, valued at
$22.5k
|
|
| 05/01/2023 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 863 shares
@ $11.16, valued at
$9.6k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 101,115 shares
@ $0
Granted 104,600 options to buy
@ $20.45, valued at
$2.1M
Granted 97,630 options to buy
@ $20.45, valued at
$2M
|
|
| 12/28/2022 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 445 shares
@ $14.49, valued at
$6.4k
|
|
| 09/29/2022 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 443 shares
@ $22.73, valued at
$10.1k
|
|
| 09/08/2022 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 26,257 shares
@ $30, valued at
$787.7k
Exercised 26,257 options to buy
@ $4.12, valued at
$108.2k
|
|
| 07/29/2022 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 734 shares
@ $21.26, valued at
$15.6k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2022 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 725 shares
@ $25.57, valued at
$18.5k
|
|
| 03/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 13,286 shares
@ $30, valued at
$398.6k
Exercised 13,286 options to buy
@ $4.12, valued at
$54.7k
|
|
| 01/31/2022 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 39,270 shares
@ $0
Granted 78,540 options to buy
@ $20.38, valued at
$1.6M
|
|
| 12/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2021 |
4
| Catinazzo Thomas (Senior Vice President, Finance) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 22,500 shares
@ $35.4, valued at
$796.5k
Exercised 22,500 options to buy
@ $4.12, valued at
$92.7k
|
|
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Catinazzo Thomas (Senior Vice President, Finance) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 63,363 options to buy
@ $5.22, valued at
$330.8k
|
|
| 07/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |